Jackson Creek Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Jackson Creek Investment Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$408K	Sell	27,558 -45	-0.2%	-$658	0.12%	253
2025 Q4	$440K	Buy	+27,603	New	+$391K	0.13%	223
2024 Q1	–	Sell	-97,492	Closed	-$876K	–	302
2023 Q4	$876K	Sell	97,492 -21	-0%	-$173	0.34%	165
2023 Q3	$758K	Sell	97,513 -69	-0.1%	-$675	0.32%	173
2023 Q2	$945K	Buy	97,582 +5,949	+6%	+$61.7K	0.38%	115
2023 Q1	$1M	Buy	+91,633	New	+$807K	0.42%	52

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jackson Creek Investment Advisors's AUPH Position: Q1 2026 in Review

Jackson Creek Investment Advisors reduced its Aurinia Pharmaceuticals (AUPH) stake by 0.16% in Q1 2026, selling an estimated $658 and leaving 27,558 shares worth $408K. The position accounts for 0.12% of the portfolio, ranked #253.

Jackson Creek Investment Advisors first reported a position in AUPH in Q1 2023 and has held it in 6 quarters since. The position peaked at $1M in Q1 2023. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

Jackson Creek Investment Advisors held 27,558 shares of Aurinia Pharmaceuticals worth $408K as of Q1 2026.
Jackson Creek Investment Advisors sold 45 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $658.
Aurinia Pharmaceuticals made up 0.12% of Jackson Creek Investment Advisors's portfolio in Q1 2026, its #253 holding.
Jackson Creek Investment Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
Jackson Creek Investment Advisors's Aurinia Pharmaceuticals position peaked at $1M in Q1 2023.
259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.